Dianthus Therapeutics (DNTH) Return on Sales (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Return on Sales of 4.11% for Q3 2025, down 377.0% year-over-year from 1.48% in Q3 2024, and down 56.95% quarter-over-quarter from 2.62% in Q2 2025.
Dianthus Therapeutics (DNTH) Return on Sales (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Return on Sales history runs 4 years deep, the most recent figure standing at 4.11% for Q3 2025.
- In Q3 2025, Return on Sales fell 377.0% year-over-year to 4.11%; the TTM figure through Sep 2025 stood at 0.91% (down 50.0% YoY), while the FY2024 annual figure was 0.43%, up 16.0% from the prior year.
- Return on Sales for Q3 2025 stood at 4.11%, down from 2.62% in the prior quarter.
- The five-year high for Return on Sales was 0.09% in Q4 2022, with the low at 4.11% in Q3 2025.
- The 4-year median for Return on Sales is 0.34% (2024), against an average of 0.77%.
- Peak annual rise in Return on Sales reached 43 bps in 2025, while the deepest fall reached 377 bps in 2025.
- Dianthus Therapeutics' Return on Sales stood at 0.09% in 2022, then plunged by 188 bps to 0.25% in 2023, then climbed by 14 bps to 0.21% in 2024, then tumbled by 1839 bps to 4.11% in 2025.
- Business Quant data shows DNTH's Return on Sales at 4.11% in Q3 2025, 2.62% in Q2 2025, and 0.36% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.11% |
| Jun 30, 2025 | -2.62% |
| Mar 31, 2025 | -0.36% |
| Dec 31, 2024 | -0.21% |
| Sep 30, 2024 | -0.34% |
| Jun 30, 2024 | -0.35% |
| Mar 31, 2024 | -0.79% |
| Dec 31, 2023 | -0.25% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.11% |
| Mar 31, 2023 | -0.14% |
| Dec 31, 2022 | -0.09% |
| Sep 30, 2022 | -0.42% |